Trial Profile
Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine H7N9 Hualan Biological Bacterin (Primary)
- Indications Influenza A virus H7N9 subtype
- Focus Adverse reactions
- Sponsors Hualan Biological Bacterin
- 03 Jul 2017 New trial record